Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: PINE PHARMACEUTICALS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-06-20 to 2026-01-31
Current total value of award: $121989
Description: PINE PHARMACEUTICALS, LLC:1270808 [25-001246] THE CURRENT TRIAL RELIES ON UNIFORMITY OF DRUG FORMULATION, EXCIPIENT COMPOSITION, APPEARANCE, AND PACKAGING THROUGHOUT THE STUDY PERIOD.